Abstract: Systems and methods are provided for avoiding in-device coexistence interference on a user equipment. A first wireless communication circuitry and a second wireless communication circuitry operate concurrently on the user equipment. The second wireless communication circuitry detects an operational status of the first wireless communication circuitry, and determines if the operational status is transmission or reception. In response to determining that the operational status is transmission, the second wireless communication circuitry avoids receiving data. In response to determining that the operational status is reception, the second wireless communication circuitry avoids transmitting data.

Abstract: An electronic device includes a housing, an indicator plate, a circuit board, a shading case, and a guiding light member. The indicator plate is attached to an outside surface of the housing and defines a receiving hole. The circuit board is attached in the housing. The indicator light is electrically connected to the circuit board. The shading case and the circuit board together encircle the first indicator light. An end of the first shading case abuts the housing and defines a first through hole. The guiding light member is attached between the first through hole and the first receiving hole. Light emitted from the indicator light passes through the through hole to be transmitted to the receiving hole through the guiding light member.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: Provided herein is a new class of cyclic lactadherin peptides (cLac) that mimic the natural phosphatidylserine (PS)-binding activity of the parent lactadherin protein. These cLacs are useful as small molecule indicators of early stage of apoptosis and of treatment efficacy evaluation.

Abstract: Interacted starch products made up of resistant starch and hydrocolloid are provided which exhibit at least about 20% resistance to ?-amylase digestion. The products are prepared by mixing together quantities of resistant starch and hydrocolloid in water with mixing and optional heating, followed by drying. Foods containing the interacted starch products are also disclosed.

Abstract: Provided herein are compounds useful for selectively labeling an apoptotic cell, and methods and assays using such compounds for the detection of an apoptotic cell in vivo or in a biological sample obtained from a subject.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: Systems and methods are provided for avoiding in-device coexistence interference on a user equipment. A first wireless communication circuitry and a second wireless communication circuitry operate concurrently on the user equipment. The second wireless communication circuitry detects an operational status of the first wireless communication circuitry, and determines if the operational status is transmission or reception. In response to determining that the operational status is transmission, the second wireless communication circuitry avoids receiving data. In response to determining that the operational status is reception, the second wireless communication circuitry avoids transmitting data.

Abstract: The present invention discloses a high electrochemical performance silicon/graphene composite anode structure. The electrochemical properties of silicon in the composite anode structure can be improved by graphene thin films. The thickness of the silicon thin film and the graphene thin films is less than 50 nm to prevent the composite anode structure from any volumetric change during the charge/discharge process. The manufacturing procedure starts with the formation of a Si/graphene unit layer, which includes an amorphous phase upper silicon thin film and a lower graphene thin film, on a copper foil current collector, so as to decrease the difference of conductivity between the silicon thin film and the copper foil current collector. Finally, the deposition is concluded with the formation of a graphene thin film on the topmost surface of the silicon thin film to prevent the surface of the anode structure from oxidation.

Abstract: Provided herein is a new class of cyclic lactadherin peptides (cLac) that mimic the natural phosphatidylserine (PS)-binding activity of the parent lactadherin protein. These cLacs are useful as small molecule indicators of early stage of apoptosis and of treatment efficacy evaluation.

Abstract: A support device includes a supporting portion touching and resisting on workpieces, a holding portion and a driving portion. The supporting portion elastically connects with the holding portion to adjust a relative position with the holding portion according to size of the workpieces. The supporting portion includes a supporting part and a first spring. The holding portion is driven by the driving portion to fasten the supporting portion to the holding portion when the relative position is determined. The holding portion includes a driving plate, a lid portion, a plurality of fixing blocks, a plurality of second springs, a first cover and a connecting part. The driving portion is used to drive the holding portion to engage with the supporting portion by the means of air pressure or hydraulic pressure, and includes a driving portion, a piston and a motherboard.

Abstract: Provided herein are compounds useful for selectively labeling an apoptotic cell, and methods and assays using such compounds for the detection of an apoptotic cell in vivo or in a biological sample obtained from a subject.

Abstract: A light emitting diode module includes a substrate, at least two spaced apart light emitting diodes formed on the substrate, an insulating layer, and an electrically conductive layer. Each of the light emitting diodes includes a light emitting unit, an n-electrode, and a p-electrode. The light emitting unit has first and second portions. The first portion has an n-type top face and a first stepped side. The second portion has a p-type top face and a second stepped side. The insulating layer is formed on the n-type top face and the first stepped side of the first portion of one of the light emitting diodes, and the second stepped side and the p-type top face of the second portion of the other one of the light emitting diodes. The electrically conductive layer is formed on the insulating layer. A method of making the light emitting diode module is also disclosed.

Abstract: A polypeptide containing epitope of the amino acid sequence shown in SEQ ID NO:3 is provided, which is selected from the amino acid sequence of SEQ ID NO:3 and amino acids at 16-32 positions, amino acids at 1-30 positions, amino acids at 50-80 positions and amino acids at 17-200 positions of the amino acid sequence shown in SEQ ID NO:3. The nucleic acid molecule encoding the polypeptide, recombinant vectors and host cells comprising the nucleic acid molecule are also provided. The polypeptide and the nucleic acid molecule encoding it can be used for preparing reagents, kits or devices for diagnosing the diseases characterized by EECP expression and pharmaceutical compositions for preventing or treating the diseases characterized by EECP expression by increasing or inhibiting EECP expression and/or activity.

Abstract: A light emitting diode module includes a substrate, at least two spaced apart light emitting diodes formed on the substrate, an insulating layer, and an electrically conductive layer. Each of the light emitting diodes includes a light emitting unit, an n-electrode, and a p-electrode. The light emitting unit has first and second portions. The first portion has an n-type top face and a first stepped side. The second portion has a p-type top face and a second stepped side. The insulating layer is formed on the n-type top face and the first stepped side of the first portion of one of the light emitting diodes, and the second stepped side and the p-type top face of the second portion of the other one of the light emitting diodes. The electrically conductive layer is formed on the insulating layer. A method of making the light emitting diode module is also disclosed.

Abstract: A support device includes a supporting portion touching and resisting on workpieces, a holding portion and a driving portion. The supporting portion elastically connects with the holding portion to adjust a relative position with the holding portion according to size of the workpieces. The supporting portion includes a supporting part and a first spring. The holding portion is driven by the driving portion to fasten the supporting portion to the holding portion when the relative position is determined. The holding portion includes a driving plate, a lid portion, a plurality of fixing blocks, a plurality of second springs, a first cover and a connecting part. The driving portion is used to drive the holding portion to engage with the supporting portion by the means of air pressure or hydraulic pressure, and includes a driving portion, a piston and a motherboard.

Abstract: A polypeptide containing epitope of the amino acid sequence shown in SEQ ID NO:3 is provided, which is selected from the amino acid sequence of SEQ ID NO:3 and amino acids at 16-32 positions, amino acids at 1-30 positions, amino acids at 50-80 positions and amino acids at 17-200 positions of the amino acid sequence shown in SEQ ID NO:3. The nucleic acid molecule encoding the polypeptide, recombinant vectors and host cells comprising the nucleic acid molecule are also provided. The polypeptide and the nucleic acid molecule encoding it can be used for preparing reagents, kits or devices for diagnosing the diseases characterized by EECP expression and pharmaceutical compositions for preventing or treating the diseases characterized by EECP expression by increasing or inhibiting EECP expression and/or activity.

Abstract: The present invention relates to the regulation of the activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity. The invention further relates to methods of screening for agonists or antagonists of NET in order to identify new pro-angiogenic or anti-angiogenic compounds and to therapeutic uses of these compounds. The invention also relates to transgenic animals bearing mutations in NET gene.

Abstract: Interacted starch products made up of resistant starch and hydrocolloid are provided which exhibit at least about 20% resistance to ?-amylase digestion. The products are prepared by mixing together quantities of resistant starch and hydrocolloid in water with mixing and optional heating, followed by drying. Foods containing the interacted starch products are also disclosed.